{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:21:03Z","timestamp":1768461663760,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.vaccine.2022.11.005","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T09:06:39Z","timestamp":1667984799000},"page":"7613-7621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Chitosan-functionalized graphene oxide as adjuvant in HEV P239 vaccine"],"prefix":"10.1016","volume":"40","author":[{"given":"Qianyu","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yina","family":"AN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jijing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianlong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.11.005_b0005","unstructured":"Global and regional mortality from 235 causes of death for 20 age- groups in 1990 and 2010: A systematic analysis."},{"key":"10.1016\/j.vaccine.2022.11.005_b0010","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.005_b0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jceh.2013.08.009","article-title":"Hepatitis E and Acute Liver Failure in Pregnancy","volume":"3","author":"Shalimar","year":"2013","journal-title":"J Clin Exper Hepatol"},{"key":"10.1016\/j.vaccine.2022.11.005_b0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1440-1746.2004.03188.x","article-title":"Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease","volume":"19","author":"Ramachandran","year":"2004","journal-title":"J Gastroen Hepatol"},{"key":"10.1016\/j.vaccine.2022.11.005_b0025","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1478-3231.2008.01840.x","article-title":"Hepatitis E and pregnancy: understanding the pathogenesis","volume":"28","author":"Navaneethan","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.vaccine.2022.11.005_b0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","article-title":"Hepatitis E: an emerging infection in developed countries","volume":"8","author":"Dalton","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"9744","key":"10.1016\/j.vaccine.2022.11.005_b0035","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet"},{"issue":"48","key":"10.1016\/j.vaccine.2022.11.005_b0040","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1016\/j.vaccine.2016.10.045","article-title":"Real-time stability of a hepatitis E vaccine (Hecolin\u00ae) demonstrated with potency assays and multifaceted physicochemical methods","volume":"34","author":"Zhang","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.11.005_b0045","doi-asserted-by":"crossref","first-page":"112880","DOI":"10.1016\/j.jpba.2019.112880","article-title":"Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods","volume":"177","author":"Yin","year":"2020","journal-title":"J Pharmaceut Biomed"},{"key":"10.1016\/j.vaccine.2022.11.005_b0050","unstructured":"Essential Elements of the Capsid Protein for Self-Assembly into Empty Virus-Like Particles of Hepatitis E Virus., doi:10.1128\/JVI.79.20.12999."},{"key":"10.1016\/j.vaccine.2022.11.005_b0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine Adjuvants: from 1920 to 2015 and Beyond","volume":"3","author":"Pasquale","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2022.11.005_b0060","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1021\/jacs.6b12622","article-title":"Asymmetric Silica Nanoparticles with Tunable Head-Tail Structures Enhance Hemocompatibility and Maturation of Immune Cells","volume":"139","author":"Abbaraju","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.vaccine.2022.11.005_b0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2022.11.005_b0070","doi-asserted-by":"crossref","first-page":"1700466","DOI":"10.1002\/adhm.201700466","article-title":"Understanding the Effect of Surface Chemistry of Mesoporous Silica Nanorods on Their Vaccine Adjuvant Potency","volume":"6","author":"Yang","year":"2017","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.vaccine.2022.11.005_b0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nmat4822","article-title":"Designer vaccine nanodiscs for personalized cancer immunotherapy","volume":"16","author":"Kuai","year":"2017","journal-title":"Nat Mater"},{"key":"10.1016\/j.vaccine.2022.11.005_b0080","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/smll.201301998","article-title":"In Vivo Immune Cell Distribution of Gold Nanoparticles in Na\u00efve and Tumor Bearing Mice","volume":"10","author":"Almeida","year":"2014","journal-title":"Small"},{"key":"10.1016\/j.vaccine.2022.11.005_b0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actbio.2020.06.009","article-title":"Recent progress of graphene oxide as a potential vaccine carrier and adjuvant","volume":"112","author":"Cao","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.vaccine.2022.11.005_b0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.snb.2017.11.047","article-title":"Low toxic fluorescent nanoprobe applicable for sensing pH changes in biological environment","volume":"257","author":"Lu","year":"2018","journal-title":"Sens Actuators, B"},{"key":"10.1016\/j.vaccine.2022.11.005_b0095","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/cjoc.201700070","article-title":"Photodynamic Therapy of Oligoethylene Glycol-Dendronized Reduction-Sensitive Porphyrins","volume":"35","author":"Ju","year":"2017","journal-title":"Chinese J Chem"},{"key":"10.1016\/j.vaccine.2022.11.005_b0100","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/bkcs.11552","article-title":"Redox-Responsive Nanocomposites Composed of Graphene Oxide and Chlorin e6 for Photodynamic Treatment of Cholangiocarcinoma","volume":"39","author":"Kim","year":"2018","journal-title":"B Korean Chem Soc"},{"key":"10.1016\/j.vaccine.2022.11.005_b0105","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13193","article-title":"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy","volume":"7","author":"Chen","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2022.11.005_b0110","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jiec.2019.08.038","article-title":"Simultaneous delivery of DNA vaccine and hydrophobic adjuvant using reducible polyethylenimine-functionalized graphene oxide for activation of dendritic cells","volume":"80","author":"Yin","year":"2019","journal-title":"J Ind Eng Chem"},{"key":"10.1016\/j.vaccine.2022.11.005_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120421","article-title":"Photo-activated chemo-immunotherapy for metastatic cancer using a synergistic graphene nanosystem","volume":"265","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2022.11.005_b0120","doi-asserted-by":"crossref","first-page":"39014","DOI":"10.1021\/acsami.0c12078","article-title":"Lentinan-Functionalized Graphene Oxide Is an Effective Antigen Delivery System That Modulates Innate Immunity and Improves Adaptive Immunity","volume":"12","author":"Liu","year":"2020","journal-title":"Acs Appl Mater Inter"},{"key":"10.1016\/j.vaccine.2022.11.005_b0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00005-015-0369-3","article-title":"The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions","volume":"64","author":"Dudek","year":"2016","journal-title":"Arch Immunol Ther Ex"},{"key":"10.1016\/j.vaccine.2022.11.005_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.110899","article-title":"Polyurethane nanocomposite impregnated with chitosan-modified graphene oxide as a potential antibacterial wound dressing","volume":"115","author":"Najafabadi","year":"2020","journal-title":"Mater Sci Eng, C"},{"key":"10.1016\/j.vaccine.2022.11.005_b0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/nano7030059","article-title":"Chitosan-Functionalized Graphene Oxide as a Potential Immunoadjuvant","volume":"7","author":"Yan","year":"2017","journal-title":"Nanomaterials-Basel"},{"key":"10.1016\/j.vaccine.2022.11.005_b0140","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.msec.2016.12.072","article-title":"Graphene oxide-chitosan nanocomposites for intracellular delivery of immunostimulatory CpG oligodeoxynucleotides","volume":"73","author":"Zhang","year":"2017","journal-title":"Mater Sci Eng, C"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.005_b0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.addr.2009.11.009","article-title":"Chitosan-based delivery systems for protein therapeutics and antigens","volume":"62","author":"Amidi","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"issue":"22","key":"10.1016\/j.vaccine.2022.11.005_b0150","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.vaccine.2004.11.064","article-title":"A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates","volume":"23","author":"Li","year":"2005","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2022.11.005_b0155","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.vaccine.2018.03.005","article-title":"Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro","volume":"36","author":"Zheng","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.11.005_b0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2016.02.002","article-title":"Immunogenicity difference between two hepatitis E vaccines derived from genotype 1 and 4","volume":"128","author":"Wen","year":"2016","journal-title":"Antivir Res"},{"key":"10.1016\/j.vaccine.2022.11.005_b0165","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.eurpolymj.2016.08.024","article-title":"Benzoxazine-functionalized graphene oxide for synthesis of new nanocomposites","volume":"83","author":"Biru","year":"2016","journal-title":"Eur Polym J"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.005_b0170","doi-asserted-by":"crossref","first-page":"e3906","DOI":"10.1002\/aoc.3906","article-title":"Buchwald-Hartwig amination reaction of aryl halides using heterogeneous catalyst based on Pd nanoparticles decorated on chitosan functionalized graphene oxide","volume":"32","author":"Sarvestani","year":"2018","journal-title":"Appl Organomet Chem"},{"key":"10.1016\/j.vaccine.2022.11.005_b0175","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0264-410X(96)00233-2","article-title":"Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid","volume":"15","author":"Gupta","year":"1997","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.11.005_b0180","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.bbrc.2016.08.054","article-title":"CLOCK modulates survival and acute lung injury in mice with polymicrobial sepsis","volume":"478","author":"Wang","year":"2016","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.vaccine.2022.11.005_b0185","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.apsusc.2018.01.175","article-title":"Surface modification of graphene oxide nanosheets by protamine sulfate\/sodium alginate for anti-cancer drug delivery application","volume":"440","author":"Xie","year":"2018","journal-title":"Appl Surf Sci"},{"key":"10.1016\/j.vaccine.2022.11.005_b0190","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1016\/j.ceramint.2018.12.070","article-title":"Chitosan and dextran stabilized GO-iron oxide nanosheets with high dispersibility for chemotherapy and photothermal ablation","volume":"45","author":"Zhang","year":"2019","journal-title":"Ceram Int"},{"key":"10.1016\/j.vaccine.2022.11.005_b0195","article-title":"Green preparation of reduced graphene oxide for sensing and energy storage applications","volume":"4","author":"Bo","year":"2015","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.vaccine.2022.11.005_b0200","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1773-2247(10)50006-6","article-title":"Progress in chitosan-based vaccine delivery systems","volume":"20","author":"Esmaeili","year":"2010","journal-title":"J Drug Deliv Sci Tec"},{"issue":"10","key":"10.1016\/j.vaccine.2022.11.005_b0205","doi-asserted-by":"crossref","DOI":"10.1007\/s13205-018-1437-2","article-title":"Cloning and expression of truncated ORF2 as a vaccine candidate against hepatitis E virus","volume":"8","author":"Rani","year":"2018","journal-title":"3 Biotech"},{"key":"10.1016\/j.vaccine.2022.11.005_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118050","article-title":"Immunostimulatory effect of chitosan and quaternary chitosan: A review of potential vaccine adjuvants","volume":"264","author":"Li","year":"2021","journal-title":"Carbohyd Polym"},{"key":"10.1016\/j.vaccine.2022.11.005_b0215","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1080\/21645515.2017.1331191","article-title":"N-(2-hydroxy) propyl-3-trimethylammonium chitosan chloride: An immune-enhancing adjuvant for hepatitis E virus recombinant polypeptide vaccine in mice","volume":"13","author":"Tao","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.11.005_b0220","unstructured":"REGULATION OF ANTIBODY RESPONSES VIA ANTIBODIES,COMPLEMENT, AND FC RECEPTORS Birgitta Heyman.."},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.005_b0225","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ejpb.2012.03.021","article-title":"Novel thermal-sensitive hydrogel enhances both humoral and cell-mediated immune responses by intranasal vaccine delivery","volume":"81","author":"Wu","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2022.11.005_b0230","doi-asserted-by":"crossref","first-page":"9963","DOI":"10.1016\/j.biomaterials.2014.08.036","article-title":"Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal\/immune cancer therapy","volume":"35","author":"Tao","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2022.11.005_b0235","first-page":"285","article-title":"Immunostimulatory properties of glycated chitosan","volume":"19","author":"Zhou","year":"2011","journal-title":"J X-Ray Sci Technol"},{"key":"10.1016\/j.vaccine.2022.11.005_b0240","first-page":"1180783193","article-title":"An Immunologically Modified Nanosystem Based on Noncovalent Binding Between Single-Walled Carbon Nanotubes and Glycated Chitosan","volume":"17","author":"Saha","year":"2018","journal-title":"Technol Cancer Res T"},{"key":"10.1016\/j.vaccine.2022.11.005_b0245","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nano.2018.09.008","article-title":"Trimodal synergistic antitumor drug delivery system based on graphene oxide","volume":"15","author":"Zhang","year":"2019","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.vaccine.2022.11.005_b0250","doi-asserted-by":"crossref","first-page":"32946","DOI":"10.1021\/acsami.8b06804","article-title":"Comparisons between Graphene Oxide and Graphdiyne Oxide in Physicochemistry Biology and Cytotoxicity","volume":"10","author":"Zheng","year":"2018","journal-title":"Acs Appl Mater Inter"},{"key":"10.1016\/j.vaccine.2022.11.005_b0255","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1039\/C8NR02933D","article-title":"Graphene and graphene oxide induce ROS production in human HaCaT skin keratinocytes: the role of xanthine oxidase and NADH dehydrogenase","volume":"10","author":"Pelin","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.vaccine.2022.11.005_b0260","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Flores, K.G.; Calder\u00f3n-Garcidue\u00f1as, A.L.; Mellado-S\u00e1nchez, G.; Ruiz-Ramos, R.; S\u00e1nchez-Vargas, L.A.; Thomas-Dupont, P.; Izaguirre-Hern\u00e1ndez, I.Y.; T\u00e9llez-Sosa, J.; Mart\u00ednez-Barnetche, J.; Wood, L., et al. Evaluation of the safety and adjuvant effect of a detoxified listeriolysin O mutant on the humoral response to dengue virus antigens. Clinical & Experimental Immunology 2017, 188, 109-126, doi:10.1111\/cei.12906.","DOI":"10.1111\/cei.12906"},{"key":"10.1016\/j.vaccine.2022.11.005_b0265","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1021\/acsnano.7b07734","article-title":"Live Imaging of Label-Free Graphene Oxide Reveals Critical Factors Causing Oxidative-Stress-Mediated Cellular Responses","volume":"12","author":"Vranic","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.vaccine.2022.11.005_b0270","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.carbon.2010.11.005","article-title":"Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration","volume":"49","author":"Zhang","year":"2011","journal-title":"Carbon"},{"key":"10.1016\/j.vaccine.2022.11.005_b0275","doi-asserted-by":"crossref","unstructured":"Li, B.; Zhang, X.; Yang, J.; Zhang, Y.; Li, W.; Fan, C.; Huang, Q. Influence of polyethylene glycol coating on\u00a0biodistribution and toxicity of nanoscale graphene oxide in mice after intravenous injection. Int J Nanomed, 4697, doi:10.2147\/IJN.S66591.","DOI":"10.2147\/IJN.S66591"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22013755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22013755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:21:57Z","timestamp":1759404117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22013755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":55,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0264410X22013755"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chitosan-functionalized graphene oxide as adjuvant in HEV P239 vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}